To have a product in time for the
"Opioid Alternative Innovation Challenge ProgramPress Release " one would have to figure that BEFORE that announcement, in November of the winners, the 510(K) must be in hand ie SE'd (approved).
So, with tongue in cheek, the max time frame would have to be November. However weeks before would be more realistic. That puts us in the early October timeframe or sooner.
The price will go up for sure, BUT as always fundamentals rule, ie profits. Profits set your support levels in my opinion. So, yes with FDA full approval we go up, with "Opioid Alternative Innovation Challenge Program" we will go up exponentially. That will be a ginaormous selling point. Doc's won't need to research out the efficacy, they will just use ASAP because they know how highly rated it is.
PRO_BIEL as always.